Radhika Ananth joined Accel in 2017 and is a Vice President.
Radhika is part of the investment team, where she focuses on investments in seed/early-stage health tech companies. She covers life-sciences, medical technologies, digital health, and healthcare delivery.
She has an educational background in life-sciences and is particularly passionate about scientific advancements in oncology and neurosciences, precision medicine, and AI applications in healthcare. Prior to joining Accel, she worked at BCG and Frost & Sullivan, providing subject area expertise within healthcare and strategy practices.
Radhika grew up in Madras and holds a master’s degree in Entomology, with specialization in Bioinformatics from Kansas State University, and a bachelor’s degree in Neurosciences from Sri Ramachandra Medical College.